Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Overview: The demand for programming skills in 2026 centres around versatility, performance, and scalability as companies ramp up AI, cloud, and web services.La ...

anthropomorphism: When humans tend to give nonhuman objects humanlike characteristics. In AI, this can include believing a chatbot is more humanlike and aware than it actually is, like believing it's ...

From Uncertainty to a Clear Path Forward Some careers follow a straight line. Others take shape through grit, trial and error ...

Newer languages might soak up all the glory, but these die-hard languages have their place. Here are eight languages ...

Utah land managers released a new map, outlining nearly 60,000 "high risk" wildland urban interface structures all over the ...

Overview Python projects in 2026 emphasize hands-on learning through real-world use cases rather than purely academic examples.Beginner projects focus on logic ...

AI is now a core part of business strategy, and leaders who understand how to use it can make faster decisions, drive ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Days after its recent licensing deal with AI chip firm Groq, Nvidia is reportedly acquiring Israel AI firm AI21 Labs for a ...

The bureau is accelerating a global biometric screening architecture that is designed to identify and disrupt individuals ...